Position in PSNL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,330,635
+$552,370 QoQ
Shares Held
208,891
+113.7% QoQ
Ownership
0.199%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PSNL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026HRT FINANCIAL LP holds $54,922,173 across 15 Diagnostics & Research names. PSNL ranks #6 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
177,683 | $33,688,696 | |
| 2 | MYGN |
Myriad Genetics Inc
|
1,786,319 | $8,038,435 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
7,571 | $3,635,518 | |
| 4 | QGEN |
Qiagen N.V.
|
72,302 | $2,894,972 | |
| 5 | SHC |
Sotera Health Co
|
139,192 | $1,996,013 | |
| 6 | PSNL |
Personalis, Inc.
This page
|
208,891 | $1,330,635 | |
| 7 | VCYT |
Veracyte, Inc.
|
31,312 | $1,008,559 | |
| 8 | FLGT |
Fulgent Genetics, Inc.
|
46,448 | $738,523 |
All Filings in PSNL
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,330,635 | 208,891 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $778,265 | 97,772 | Shares | Defined | 2026-02-12 | |
| 2025-03-31 | $621,599 | 177,094 | Shares | Defined | 2025-05-15 | |
| 2024-03-31 | $63,189 | 42,409 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $22,551 | 10,739 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $22,313 | 18,441 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $37,419 | 19,904 | Shares | Defined | 2023-08-11 | |
| 2022-06-30 | $161,832 | 46,908 | Shares | Defined | 2022-08-12 | |
| 2021-03-31 | $879,118 | 35,722 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,315,399 | 63,245 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||